Trial Profile
Impact of Ranolazine on Inflammatory, Thrombogenic, Lipogenic, Biomarkers in Women With Angina and Metabolic Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms IRMA
- 31 May 2019 Status changed from active, no longer recruiting to completed.
- 08 Jan 2019 Planned End Date changed from 1 Nov 2018 to 1 Mar 2019.
- 08 Jan 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Mar 2019.